EPIM-001

N/A

Report date: 2024/12/04 13:50:29

Base Information

Drug NameEPIM-001
Drug Alias NameEPIM-001
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionInterleukin-2 receptor beta chain agonistsAnti-Programmed death-ligand 1
TargetsInterleukin-2 receptor beta chainProgrammed death-ligand 1
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesElpiscience (Shanghai) Biopharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesElpiscience (Shanghai) Biopharma Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A